The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Chaudhury, Chaity, Mehnaz, Samina, Robinson, John M., Hayton, William L., Pearl, Dennis K., Roopenian, Derry C., Anderson, Clark L.·2003·The Journal of Experimental Medicine
DOI 10.1084/jem.20021829

Cited by (642)

Items 501–600 of 642

  1. Field-Flow Fractionation for Assessing Biomolecular Interactions in Solution
    Robert Chou, Joey Pollastrini, Thomas M. Dillon, Pavel V. Bondarenko, L T Tam, Jill M. Miller, Michael S. Moxness, Shawn Cao · 2011 · Springer eBooks
  2. A Survey and Guide to the Development of Fatty Acid‐derivatized Peptide Therapeutics
    Michael T. Jacobsen, Christian Poulsen, Katharina L. Kopp, Jørgen Olsen, Nick Cox · 2025 · Peptide Science
  3. Advanced human FcRn knock-in mice for pharmacokinetic profiling of therapeutic antibodies
    SuBin Lee, Munsu Kyung, Miyeon Park, Sunha Park, Jae Hoon Lee, Suyeon Kim, Seunghyeon Lee, Migyeong Jo, Sang Taek Jung, Han-Woong Lee · 2025 · Scientific Reports
  4. Albubody: an engineered scFv variant platform for site-specific drug conjugation and enhanced tumor efficacy
    Na Hyun Kwon, Jae Hun Lee, Yeongchae Kim, Young S. Hahn, Inchan Kwon · 2025 · Journal of Controlled Release
  5. Molecular engineering of designer diabetes therapeutics
    Emily L. DeWolf, Bernice Webber, Matthew J. Webber · 2026 · Journal of Controlled Release
  6. Protein-based nanocarriers in the management of hard-to-treat solid tumours
    Alexander S. Evtushenko, Beatriz Lozano Torres, Ljiljana Fruk · 2026 · Advanced Drug Delivery Reviews
  7. The tryptic peptides of hemoglobin for diagnosis of type 2 diabetes mellitus using label-free and standard-free LC-ESI-DMRM
    Jie Hong, Shuchen Xin, Rui Min, Yongqian Zhang, Yulin Deng · 2021 · Redox Biology
  8. Virally Induced CRISPR/Cas9-Based Knock-In of Fluorescent Albumin Allows Long-Term Visualization of Cerebral Circulation in Infant and Adult Mice
    Marta Vittani, Philip Gade Knak, Masahiro Fukuda, Masaki Nagao, Xiaowen Wang, Celia Kjærby, Ayumu Konno, Hirokazu Hirai, Maiken Nedergaard, Hajime Hirase · 2024 · Neuromethods
  9. Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life
    Simone Mester, Chilam Chan, Marta Lustig, Stian Foss, J.H. Marco Jansen, Marie Leangen Herigstad, Mitchell Evers, Jeannette Nilsen, Karli R. Reiding, Mirjam J. A. Damen et al. · 2025 · PNAS Nexus
  10. Truncation of the Murine Neonatal Fc Receptor Cytoplasmic Tail Does Not Alter IgG Metabolism or Transport In Vivo
    Yonghe Ma, Cuncun Ke, Zihui Wan, Zili Li, Xueqian Cheng, Xifeng Wang, Jinshan Zhao, Youji Ma, Liming Ren, Haitang Han et al. · 2018 · The Journal of Immunology
  11. Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy
    Shanshan Chen, Yiqun Han, Quchang Ouyang, Jianguo Lu, Qingyuan Zhang, Yang Shun-e, Jingfen Wang, Haixin Huang, Hong Liu, Zhimin Shao et al. · 2021 · BMC Cancer
  12. The X-Ray Crystallographic Structure of the Human Neonatal Fc Receptor at Acidic pH Gives Insights into pH-Dependent Conformational Changes
    Mohammed Taha, Sally E. Ward, Hyun-Joo Nam · 2016 · Protein and Peptide Letters
  13. Using 2-photon microscopy to understand albuminuria.
    Bruce A. Molitoris · 2014 · Europe PMC (PubMed Central)
  14. Pharmacokinetics and pharmacodynamics of protein turnover and production in vivo
    Jonghan Kim · 2004 · OhioLink ETD Center (Ohio Library and Information Network)
  15. Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics
    Srinivas Akula, Perla Abigail Alvarado-Vazquez, Erika Haid Mendez Enriquez, Gürkan Bal, Kristin Franke, Sara Wernersson, Jenny Hallgren, Gunnar Pejler, Magda Babina, Lars Hellman · 2024 · International Journal of Molecular Sciences
  16. Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy
    Changjun Yu, Faqing Huang, Leslie Wang, Mengmeng Liu, Warren Allen Chow, Xiang Ling, Fengzhi Li, Galen Cook‐Wiens, Linrong Li, Xiaojiang Cui · 2025 · Cancers
  17. Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette–dosed mice
    Justin D. Walter, Michał Beffinger, Pascal Egloff, Iwan Zimmermann, Lea M. Hürlimann, Fabian Ackle, Matthias Seifert, Sebastian Kobold, Johannes vom Berg, Markus A. Seeger · 2025 · Proceedings of the National Academy of Sciences
  18. Molecular engineering approaches to half-life extension of therapeutic biomolecules
    Y. WANG, Junliang Chang, Jinghui Liu · 2026 · Frontiers in Pharmacology
  19. A novel format of TNF-α binding affibody molecule ameliorate coronary artery endothelial injury in a mouse model of Kawasaki disease
    Jinshun Zhu, Huan Yu, L X Xie, Dujuan Shuai, Zhixian Huang, Yufei Chen, Chao Ni, Chang Jia, Xing Rong, Lifang Zhang et al. · 2024 · International Journal of Biological Macromolecules
  20. Single-chain variable fragments targeting domain II of human serum albumin for enhanced circulatory half-life via albumin association
    Ae-Ran Park, Eui-Yeoung Jung, Hyeon Hui Shin, Jongha Park, Sung In Lim, Dae‐Hee Lee · 2025 · International Journal of Biological Macromolecules
  21. The underlying metabolism of hypoalbuminemia and its clinical effects
    Peter B. Soeters, Peter W. de Leeuw · 2021 · Elsevier eBooks
  22. Toward once-monthly insulin therapy via synergy in two pharmacokinetic protractors: Fc-conjugation and fatty acid acylation
    Alexander N. Zaykov, Vasily M. Gelfanov, Tina M. Tagmose, Damien Demozay, Valentina Manfé, Rebecca Rohlfs, Marita Rivir, Diego Pérez–Tilve, Brian Finan, Richard D. DiMarchi · 2024 · RSC Chemical Biology
  23. A new strategy of studying protein–protein interactions: Integrated strong anion exchange/reversed‐phase chromatography/immunoprecipitation coupled with mass spectrometry for large‐scale identification of proteins interact with immunoglobulin G in HeLa cells
    Feng Qin, Xuantang Wang, Guoquan Yan, Mingxia Gao, Xiangmin Zhang · 2020 · Journal of Separation Science
  24. T-cell engaging bispecific antibody therapy
    Patty A. Culp, Jeremiah D. Degenhardt, Danielle E. Dettling, Chad May · 2021 · Elsevier eBooks
  25. Imaging Potential Evaluation of Fab Derived from the Anti-EGFRvIII Monoclonal Antibody 4G1
    Shen Jing, Yujia He, Yanqiong He, Liang Wang, Jianhua Jia, Xiaomin Shan, Shuang Liu, Min Tang, Zhiping Peng, Xujie Liu · 2018 · Radiation Research
  26. FcRn antagonists in ITP
    Adrian C. Newland, Vickie McDonald · 2020 · Annals of Blood
  27. Branched Chain Amino Acid Supplementation and Plasma Albumin
    Masashi Kuwahata, Yasuhiro Kido · 2014 · Springer eBooks
  28. Biodistribution and Imaging
    Tove Olafsen, Anna M. Wu · 2009 · Wiley eBooks
  29. The effect of feed ingredients on feed manufacturing and growth performance of pigs
    C N Groesbeck · 2007 · K-State Research Exchange (Kansas State University)
  30. High-yield production of recombinant CLCF1 protein fused with human serum albumin in animal cells and toxicity evaluation in rodents
    Jeongmin Lee, Jae Soon Kang, Yong Ryoul Yang, Ji Hoon Park · 2025 · Protein Expression and Purification
  31. Impact of timing of a second colostrum feeding on serum immunoglobulin G dynamics in calves during the first week of life
    Maximilian A.E. von Riedheim, Hannes Erkinger, J.J. Gross · 2025 · JDS Communications
  32. Tumor-Targeted Delivery of an EGFR Inhibitor Prodrug via Site-Specific Albumin Conjugation
    Anja Federa, Rastislav Pitek, Orsolya Dömötör, Éva A. Enyedy, Alessio Terenzi, Monika Caban, Alessia Stefanelli, Luisa D’Anna, Faye White, Petra Heffeter et al. · 2026 · Journal of Medicinal Chemistry
  33. Bacteriophage Lysins as Programmable Antimicrobials: Mechanisms, Engineering, and Translational Advances
    Wenxin Ma, Yan Lei, Luyao Wang, Yingtong Chen, Min Ma, Xia Chen · 2026 · Probiotics and Antimicrobial Proteins
  34. Iridoid glucoside attenuates hyperglycemia-mediated oxidative stress and thyroid hormone function in streptozotocin–induced diabetic rats
    R. Sundaram, Palanivelu Shanthi, Panchanatham Sachdanandam · 2014 · Biomedicine & Preventive Nutrition
  35. Transport of antibody into the skin is only partially dependent upon the neonatal Fc-receptor
    Gibran Nasir, Photini Sinnis · 2023 · PLoS ONE
  36. Site-selective fatty acid chain conjugation of the N-terminus of the recombinant human granulocyte colony-stimulating factor
    Xudong Wang, Zhihao Su, Jie Du, Weijia Yu, Wenlong Sun · 2024 · Frontiers in Bioengineering and Biotechnology
  37. Surmounting an Impasse of FcRn Structure
    Clark L. Anderson, Jonghan Kim · 2013 · Structure
  38. Imparting Albumin-Binding Affinity to a Human Protein by Mimicking the Contact Surface of a Bacterial Binding Protein
    Satoshi Oshiro, Shinya Honda · 2014 · ACS Chemical Biology
  39. Thesis for the Master of Science Degree in Molecular Biosciences main field of study in Immunology FcRn expression, ligands binding properties and its regulation in human immune cells and hepatocytes
    Muluneh Bekele Daba · 2007
  40. A Comprehensive Study of Human Serum Albumin Interaction With Trimethoprim Using Molecular Docking and Molecular Dynamics Methods: An Appropriate Tool for Drug Delivery Systems
    Mitra Salehi, Hanifeh Shariatifar, Morteza Ghanbari Johkool, Alireza Farasat · 2021 · The Journal of Qazvin University of Medical Sciences
  41. GLP ‐1 Receptor Agonists for the Treatment of Type 2 Diabetes and Obesity
    Lars Linderoth, Jacob Kofoed, János T. Kodra, Steffen Reedtz‐Runge, Thomas Kruse · 2021
  42. Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells
    Carola Maria Morell, Samantha Grace Tilson, Rute A. Tomaz, Arash Shahsavari, Andi Munteanu, Giovanni Canu, Brandon Tyler Wesley, Marion Perrin, Imbisaat Geti, Subhankar Mukhopadhyay et al. · 2024 · eLife
  43. Extending Antibody Fragment Half-Lives with Albumin
    Jan Terje Andersen, Inger Sandlie · 2009 · Cambridge University Press eBooks
  44. Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
    Adriana Temporão, Margarida Sanches‐Vaz, Rafael Luís, Helena Nunes‐Cabaço, Terry Smith, Miguel Prudêncio, Luísa M. Figueiredo · 2021 · PLoS neglected tropical diseases
  45. Albumin influences leucocyte FcRn expression in the early days of kidney transplantation
    Pierre Boulard, Nicolas Azzopardi, Romain Levard, Jean-Marie Cornec, Juliette Lamamy, Bérénice Prieur, Marie-Véronique Demattei, Hervé Watier, Philippe Gatault, Valérie Gouilleux‐Gruart · 2024 · Clinical & Experimental Immunology
  46. Design, Synthesis, and Biological Evaluation of a Novel Long-Acting Human Complement C3 Inhibitor Synthesized via the PASylation–Lipidation Modular (PLM) Platform
    Chengcheng Wang, Yapeng Wang, Yu Duan, Yuanzhen Dong, Haoju Hua, Huixin Cui, Shuaiyi Huang, Zongqing Huang, Jianguang Lu, Chunyong Ding et al. · 2025 · Bioconjugate Chemistry
  47. Acute radiation exposure in mice reveals traces of oxidation-mediated modifications in serum albumin
    Masaru Yamaguchi, Yota Tatara, Yoshiaki Sato, Ikuo Kashiwakura · 2025 · PLoS ONE
  48. Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization
    Zrinka Duvnjak, Robin Michelet, Casper Steenholdt, Ella S. K. Widigson, Cæcilie Skejø, João A. Abrantes, Wilhelm Huisinga, Mette Julsgaard, Charlotte Kloft · 2025 · Clinical Pharmacology & Therapeutics
  49. Affinity- and Format-Dependent Pharmacokinetics of 89Zr-Labeled Albumin-Binding VHH Constructs
    Simon Leekens, Peter Casteels, Tom Van Bogaert, Pieter Deschaght, Veronique I. De Brabandere, Christopher Cawthorne, Guy M Bormans, Frederik Cleeren · 2026 · Pharmaceuticals
  50. Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2
    Kim G. Lieu, Sabine Pestel, Mhairi J. Maxwell, Yu-Han Liu, Greg Bass, Yun Dai, Isabelle Glauser, Marco Hofmann, Adriana Baz Morelli, Jenny Chia et al. · 2026 · Blood Cells Molecules and Diseases
  51. Internal insertion in albumin improves fusion-protein integrity while maintaining bioactivity and FcRn interaction
    Zhiyou Wang, Linan Lin, Aidi Huang, Zhiwei Huang, Hanlin Li, Dan Chen, Zepeng Huang, Wen Li, Cai Yuan, Mingdong Huang · 2026 · International Journal of Biological Macromolecules
  52. Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives
    Yuhong Shang, 王双冉, Yingyi Yan, Encheng Tian, Lan She, Zhiqiang Ma · 2026 · Pharmaceutics
  53. Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases
    Peixuan Liang, Shaozhe Cai, W J Sun, Lingli Dong · 2026 · Inflammation Research
  54. Fusion of IgG antibodies to albumin inhibits transport across the placenta
    Jeannette Nilsen, Kine Marita Knudsen Sand, Hana J. Al Khabbaz, Lennart Maximilian, Simone Mester, Line Mathiesen, Hanna Theodora Noordzij, Kjell-Rune Jensen, Nils Leitzinger, Oda Ottersen et al. · 2026 · Science Immunology
  55. Human FcRn can mediate the transport across intestinal mucosal barrier and prolong the half-life of rabbit IgG in vivo
    Guangchang Pang, Yufang Wang, Junbo Xie, Qingsen Chen, HU Zhi-he · 2015 · Brazilian Archives of Biology and Technology
  56. Regulation of Immunological Responses by the Neonatal Fc Receptor for IgG, FcRn
    Kristi Baker, Timo Räth, Richard S. Blumberg · 2013 · Springer eBooks
  57. Regulatory Effect of Nutritional Status on Albumin Synthesis
    Masashi Kuwahata · 2011 · Nippon Eiyo Shokuryo Gakkaishi
  58. The Influence of FcRn on Albumin-Fused and Targeted Drugs
    Jeannette Nilsen, Kine Marita Knudsen Sand, Malin Bern, Peng Lei, Inger Sandlie, Jan Terje Andersen · 2016 · Springer eBooks
  59. Generating a Podocyte-Specific Neonatal F Receptor (FcRn) Knockout Mouse
    Judith Tamara Blaine · 2021 · Methods in molecular biology
  60. Correlation Between Preoperative Serum Albumin Levels And Post-Operating Seroma Incidence Of Modified Radical Mastectomy In Breast Cancer Patients
    Ngakan Agung Mugi Raharja, I Gede Budhi Setiawan, Ni Gusti Ayu Agung Manik Yuniawaty Wetan, I Wayan Sudarsa, I Made Darmajaya, Gede Wirya Kusuma Duarsa · 2023 · International Journal Of Scientific Advances
  61. Advances in the Management of Diabetes and Overweight using Incretin-based Pharmacotherapies
    Shatrudhan Prajapati · 2023 · Current Diabetes Reviews
  62. Preventing osteoporotic bone loss in mice by promoting balanced bone remodeling through M-CSFRGD, a dual antagonist to c-FMS and αvβ3 receptors
    Yuval Zur, Svetlana Katchkovsky, Amit Itzhar, Chen-Viki Abramovitch-Dahan, David Stepensky, Niv Papo, Noam Levaot · 2024 · International Journal of Biological Macromolecules
  63. Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion
    Sangavi Sivananthan, Varsha Bhakta, Negin Chaeichi Tehrani, William P. Sheffield · 2024 · PLoS ONE
  64. Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study
    Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Sho Masui, Daiki Hira, Maki Inoue, Kodai Yajima, Shunsaku Nakagawa, Yasuaki Ikemi, Junzo Hamanishi et al. · 2025 · Cancer Chemotherapy and Pharmacology
  65. Protein Engineering for Molecular Imaging
    Anna M. Wu · 2021 · Elsevier eBooks
  66. Pharmacokinetics of Immunoglobulin G and Serum Albumin: Impact of the Neonatal Fc Receptor on Drug Design
    Jan Terje Andersen, Inger Sandlie · 2011
  67. Ins and outs of the IgA receptor, FcαRI
    Jantine E. Bakema · 2007 · Utrecht University Repository (Utrecht University)
  68. Development of molecular recognition by rational and combinatorial engineering
    Andreas Jonsson · 2009 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  69. Structural characterization of immunoglobulin G antibodies with LC-MS based approaches
    Yi Wang · 2012
  70. Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo.
    James F. Dylewski, Evgenia Dobrinskikh, Linda Lewis, Pantipa Tonsawan, Parmjit Jat, Judith Tamara Blaine · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Vedolizumab—A Case Example of Using Quantitative Pharmacology in Developing Therapeutic Biologics in Inflammatory Bowel Disease
    Maria Rosario, Nathanael L. Dirks, Diane R. Mould, Catherine Rose Scholz, Timothy L. Wyant, Asit Parikh, Irving H. Fox · 2019
  72. References
    2012 · Elsevier eBooks
  73. A HUMANIZED FCRN TRANSGENIC MOUSE FOR PRECLINICAL PHARMACOKINETICS STUDIES
    Christopher M. Conner, Donald Van Fossan, Kristen Read, Dale O. Cowley, Oscar Alvarez, Xiangru Xu, David R. Webb, Kurt Jarnagin · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells
    Carola Maria Morell, Samantha Grace Tilson, Rute A. Tomaz, Arash Shahsavari, Andi Munteanu, Giovanni Canu, Brandon Tyler Wesley, Marion Perrin, Imbisaat Geti, Subhankar Mukhopadhyay et al. · 2024 · eLife
  75. PROBING THE MECHANISMS OF PLATELET ADHESION TO ADSORBED PLASMA PROTEINS
    Sivaraman Balakrishnan · 2010 · TigerPrints (Clemson University)
  76. Multi-dimensional optimization of a lysin towards a ribolysin against life-threatening S. aureus infections: Fc-LysM-CHAP and its strong synergy with standard of care antibiotics
    Adriana Badarau, Benedikt Bauer, Zehra Visram, Renping Qiao, Andrea Majoros-Hashempour, Johannes Söllner, Svetlana Ðurica-Mitić, Orla M. Dunne, Robert Kluj, Donaat Kestemont et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  77. The Diverse Roles of FcRn: Implications for Antibody Engineering
    Elizabeth Sally Ward, Raimund J. Ober · 2012
  78. Proteínas plasmáticas como marcadores de peso molecular
    Rosalba Pabón, J. Ramón Camargo, Luis Fernando Arbeláez Ramírez · 2007 · Dialnet (Universidad de la Rioja)
  79. Cell line development for and characterization of mono- and bivalent antibody derivatives
    Verena Berger · 2013 · OPUS Publication Server of the University of Stuttgart (University of Stuttgart)
  80. Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
    Christoph Roland Stork · 2009 · OPUS Publication Server of the University of Stuttgart (University of Stuttgart)
  81. Modulation of Serum Protein Homeostasis and Transcytosis by the Neonatal Fc Receptor
    William F. Dall’Acqua, Herren Wu · 2009
  82. The Biology of the Neonatal Fc Receptor (FcRn)
    Jong‐Han Kim · 2012
  83. Mechanisms of respiratory syncytial virus specific T cell activation
    Debby Kruijsen · 2011 · Utrecht University Repository (Utrecht University)
  84. Influence of the antibody variable domain on FcRn-dependent pharmacokinetics
    Angela Schoch · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  85. Questões atuais relativas à dosagem e à descrição da excreção urinária de albumina
    W. Greg Miller, David E. Bruns, Glen L. Hortin, Sverre Sandberg, Kristin Moberg Aakre, Matthew McQueen, Yoshihisa Itoh, John Charles Lieske, David W. Seccombe, Graham Jones et al. · 2010 · Jornal Brasileiro de Patologia e Medicina Laboratorial
  86. A STUDY ON THE E3 LIGASE TRIM21/RO52
    Alexander Espinosa · 2008 · Figshare
  87. Monoclonal antibodies as protective medications for drug abuse during pregnancy
    Jonathan J. Hubbard · ProQuest Demo Repository
  88. Shear stress stimulated apical endocytosis in renal proximal tubule epithelia
    Venkatesan Raghavan · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  89. FcRn expression, ligands binding properties and its regulation in human immune cells and hepatocytes
    Muluneh Bekele Daba · 2007 · NORA - Norwegian Open Research Archives
  90. Szent István University Postgraduate School of Veterinary Science The transcriptional regulation of the bovine neonatal Fc receptor
    Márton Doleschall · 2007
  91. Antibody Half‐Life
    K. John Morrow · 2016
  92. Modelling Amyloidosis in Mice
    Ivana Slámová · 2016 · UCL Discovery (University College London)
  93. Reduced Proximal Tubular Expression of Megalin and Neonatal Fc Receptor in Proteinuria: The Role of Matrix Metalloproteinases
    Hiwa Ramadhan Fatah · 2018 · Leicester Research Archive (University of Leicester)
  94. Ubiquitin Engineering: Understanding Ubiquitin Recognition and Generating Affinity Reagents
    Isabel Leung · 2017 · TSpace (University of Toronto)
  95. Characterization and Engineering of Human Proteins as Therapeutic Candidates
    Kim, Kyungbo · 2018 · UKnowledge (University of Kentucky)
  96. Serum Albumin as a Carrier of Immunostimulatory Oligodeoxynucleotides for Cancer Therapy
    Patrick C. Guley · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  97. Proteomic analysis of extracellular vesicles from medullospheres reveals a role for iron in the cancer progression of medulloblastoma
    Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam, Kenneth Alan Howard · 2019 · Journal of Green Engineering
  98. Factor VIIa
    Man-Chiu Poon · 2012 · Elsevier eBooks
  99. ВПЛИВ НАТИВНИХ ЛІПОСОМ ТА ПРЕПАРАТУ «МЕМБРАНОСТАБІЛ» НА ВМІСТ ОКРЕМИХ БІЛКОВИХ ФРАКЦІЙ СИРОВАТКИ КРОВІ У НОВОНАРОДЖЕНИХ ТЕЛЯТ
    С. І. Голопура, М. І. Цвіліховський · 1970 · Вісник Полтавської державної аграрної академії
  100. An albumin-binding domain as a scaffold for bispecific affinity proteins
    Johan Nilvebrant · 2012 · Diva portal (Dalarna University Library)